Article Versions Notes

Hamdan A, AbuHaweeleh MN, Al-Qassem L, Kashkoul A, Alremawi I, Hussain U, Khan S, ElBadway MMS, Chivese T, Farooqui HH, et al. Prevalence of Antimicrobial Resistance Among the WHO’s AWaRe Classified Antibiotics Used to Treat Urinary Tract Infections in Diabetic Women. Antibiotics. 2024; 13(12):1218. https://doi.org/10.3390/antibiotics13121218

Hamdan, Ahmad, Mohannad N. AbuHaweeleh, Leena Al-Qassem, Amira Kashkoul, Izzaldin Alremawi, Umna Hussain, Sara Khan, Menatalla M. S. ElBadway, Tawanda Chivese, Habib H. Farooqui, and et al. 2024. "Prevalence of Antimicrobial Resistance Among the WHO’s AWaRe Classified Antibiotics Used to Treat Urinary Tract Infections in Diabetic Women" Antibiotics 13, no. 12: 1218. https://doi.org/10.3390/antibiotics13121218

Hamdan, A., AbuHaweeleh, M. N., Al-Qassem, L., Kashkoul, A., Alremawi, I., Hussain, U., Khan, S., ElBadway, M. M. S., Chivese, T., Farooqui, H. H., & Zughaier, S. M. (2024). Prevalence of Antimicrobial Resistance Among the WHO’s AWaRe Classified Antibiotics Used to Treat Urinary Tract Infections in Diabetic Women. Antibiotics, 13(12), 1218. https://doi.org/10.3390/antibiotics13121218